43 results on '"Mitchel Y"'
Search Results
2. Efficacy and safety of the oral PCSK9 macrocyclic peptide inhibitor MK-0616: A phase 2B randomized controlled trial
3. Making Sense of Recession
4. Stewards of the Market
5. Mike Savage. The Return of Inequality: Social Change and the Weight of the Past
6. Clifford Geertz and the Interpretation of Organizations
7. Separate spheres? The cultural contradictions of markets
8. Central Banking And The Triumph Of Technical Rationality
9. The institutional embeddedness of market failure: Why speculative bubbles still occur
10. Stewards of the Market
11. Interpretive Politics at the Federal Reserve
12. Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2–Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial
13. 10. Self-Regulation as Market Maintenance
14. Fine-Tuning the Signal: Image and Identity at the Federal Reserve
15. Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction
16. Liquidated: An Ethnography of Wall Street. By Karen Ho. Durham, N.C.: Duke University Press. Pp. 374. $24.95 (paper).
17. Narrative Construction as Sensemaking: How a Central Bank Thinks
18. Can speculative bubbles be managed? An institutional approach
19. Abstract: P1390 DESIGN OF THE DEFINE TRIAL: DETERMINING THE EFFICACY AND TOLERABILITY OF CETP INHIBITION WITH ANACETRAPIB
20. Frontiers of Capital: Ethnographic Reflections on the New Economy. Edited by Melissa S. Fisher and Greg Downey. Durham, N.C.: Duke University Press, 2006. Pp. vi+381. $23.95 (paper).
21. Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia
22. EFFECT OF NIACIN RECEPTOR PARTIAL AGONIST, MK-0354, ON PLASMA FREE FATTY ACID AND LIPID LEVELS
23. SAFETY PROFILE OF EXTENDED-RELEASE NIACIN/LAROPIPRANT IN PATIENTS WITH DYSLIPIDEMIA
24. Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire©: results from a randomised placebo-controlled clinical trial
25. Imagining the `iron cage'
26. The Creation of Trust Through Interaction and Exchange
27. Tu-W27:3 Efficacy and safety of co-administered ezetimibe/simvastatin (EZE/SIMVA) and fenofibrate (FENO) in patients with mixed hyperlipidemia
28. W16-P-063 The lipid-altering effects of INEGY-TM are consistent across gender, race, age, and baseline LDL-C levels
29. Efficacy and safety of ezetimibe co-administered with simvastatin in thiazolidinedione-treated type 2 diabetic patients
30. 3P-0870 Design of the simvastatin and szetimibe in aortic stenosis (SEAS) study
31. Book Reviews
32. Making Markets: Opportunism and Restraint on Wall Street
33. Academic evaluators versus practitioners: alternative experiences of professionalism
34. On Improving Qualitative Methods in Public Administration Research
35. MAKING SENSE OF INSTITUTIONAL CHANGE: NARRATIVES OF DE-INSTITUTIONALIZATION.
36. Markets as Cultures: An Ethnographic Approach
37. Making Markets: Opportunism and Restraint on Wall Street.
38. Procedural Entrepreneurship: Enacting Alternative Channels to Administrative Effectiveness
39. HYPER-RATIONAL GAMING
40. The Structural Embeddedness of Resistance among Public Managers
41. Long Term Experience with Simvastatin
42. Values in the Marketplace: The American Stock Market Under Federal Securities Law.James Burk
43. The Moral Dimension: Toward a New Economics.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.